Skip to main content
Caplight Logo









LumanLab

LumanLab

Private
DaejeonHealthcare & Life Scienceshttps://lumanlab.com/en

Last Round

Seed

Jun 9, 2022

Total Funding Raised

$2.4M

Company Overview

LumanLab operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a Seed round in June 2022.

LumanLab is a digital healthcare company that develops AI-driven solutions for the diagnosis and treatment of child development.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Computer Vision, Telemedicine, Patient Engagement, Home & Lifestyle

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

LumanLab Comparables

Compare LumanLab with similar companies based on industry and business-model similarity.

LumanLab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gabify
79%
GrowMatch
78%
Wowkiki Co., Ltd.
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

LumanLab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 9, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

LumanLab Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 142% MoM, reaching 2.3K.

  • Jul 1, 2025

    Monthly visitors increased 724% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

LumanLab Filings

Explore SEC and related filing metadata, where available.

LumanLab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about LumanLab's valuation, stock price, and market status.

Is LumanLab a public or private company?

LumanLab is a private company.

What is the current stock price of LumanLab?

LumanLab is a private company, so its shares have no public market price. Caplight tracks LumanLab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is LumanLab worth (valuation)?

Valuation information for LumanLab is not publicly available.

Can I buy LumanLab stock?

LumanLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was LumanLab's last funding round?

LumanLab's most recent funding round was Seed on June 9, 2022.

Who are the main investors in LumanLab?

Key investors in LumanLab include Korea Investment Partners, IMM Investment, Daol Investment & Securities.

Will LumanLab IPO soon?

No public IPO plans have been announced for LumanLab.

How can I track LumanLab secondary market activity?

Caplight tracks bids, offers, and trades in LumanLab's shares on secondary markets.

Firmographic Details

HeadquartersDaejeon
Employee Range3
Year Founded2021
Last FundingJun 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?